Linn Camilla Wergeland Digranes

Chronic Pain and Posttraumatic Stress Among Patients in Substance Use Treatment: Protocol for NOR-APT, a Longitudinal Cohort Study

Ingeborg Skjærvø, Anne Marciuch, Linn Camilla Wergeland Digranes, Lena M. Giselsson Follerås et autres

BACKGROUND: Chronic pain conditions and posttraumatic stress disorder (PTSD) are highly prevalent among patients with substance use disorders (SUDs). Both can impact outcomes of SUD treatment and quality of life. There is a need for a large-scale study on the overlap of …

no, us (code pays fourni par la source)

Chronic Pain and Posttraumatic Stress Among Patients in Substance Use Treatment: Protocol for NOR-APT, a Longitudinal Cohort Study (Preprint)

Ingeborg Skjærvø, Anne Marciuch, Linn Camilla Wergeland Digranes, Lena M. Giselsson Follerås et autres

BACKGROUND Chronic pain conditions and posttraumatic stress disorder (PTSD) are highly prevalent among patients with substance use disorders (SUDs). Both can impact outcomes of SUD treatment and quality of life. There is a need for a large-scale study on the overlap of …

Changes in mental health during long-term treatment with extended-release naltrexone: A 3-year clinical study of opioid dependent individuals

Kristin Klemmetsby Solli, Jūratė Šaltytė Benth, Linn Camilla Wergeland Digranes, Line Holtan et autres

BACKGROUND: Mental health status may be improved in patients receiving treatment with the opioid antagonist extended-release naltrexone (XR-NTX), but longer-term outcomes remain unexamined. OBJECTIVES: This study aims to assess changes in symptoms of anxiety, depression, and insomnia among opioid-dependent individuals in long-term …

no (code pays fourni par la source)

Benzodiazepine agonist treatment for patients with benzodiazepine dependence undergoing opioid agonist treatment: a study protocol for the randomized controlled trial BMX-BAR

Fatemeh Chalabianloo, Lars Thore Fadnes, Jörg Aßmus, Jon Mordal et autres

BACKGROUND: There is a lack of knowledge on effective treatment methods for comorbid benzodiazepine dependence in populations undergoing opioid agonist treatment (OAT). Tapering and discontinuation of benzodiazepines has long been considered the standard treatment, even though there is limited evidence for this …

no (code pays fourni par la source)